IMPACT OF CYP2C9 GENETIC POLYMORPHISMS ON VALPROATE DOSAGE, PLASMA CONCENTRATIONS OF VALPROATE AND CLINICAL RESPONSE TO VALPROATE
BRUSTUREAN-BOTA E.; COADǍ C.A.; TRIFA A.P.; BUZOIANU A.D.; PERJU-DUMBRAVǍ L.
This content is a part of the Agriculture and Forestry, Medicine and Healthcare
collections from eLIBRARY.
If you are interested to know more about access and subscription options, you are welcome to leave your request below or contact us by
//= __( 'Unfortunately, we have no right to provide any kind of access to this resource in the territory of Western Europe. In any case, we will process your request and contact you with possible variants of solution.',
// 'eposlink'); ?>